pharmaphorum

AUGUST 17, 2020

N o one industry is ever quite like another, but there are some valuable lessons for pharma marketing from examining how the financial sector uses technology, builds brands on social channels and approaches digital content. The key is adapting existing legacy and traditional printed material for the digital environment.”.

Regulation 97

Regulation Marketing Sales Branding 97

pharmaphorum

SEPTEMBER 15, 2020

As pharmaceutical marketers prepare their brands for the future, there are a number of important ways they can learn from digitally-native brands. Analysing the world of digitally-native brands highlights three standout ways in which parts of their approach could be brought to the pharmaceutical world.

Branding 130

Branding Marketing Pharma Companies Life Science 130

XTalks

NOVEMBER 10, 2020

Recalls and subsequent losses in sales can be financially detrimental to food companies. IoT uses a combination of mechanical and digital devices, including sensors and IP addresses, to transfer data over a network without the need for human intervention. When it comes to foodborne illness, E.

Production 105

Production Sales Manufacturing Regulation 105

XTalks

APRIL 6, 2021

Where flour, pasta and other shelf-stable goods once sat in abundance quickly emptied to nothing but price tags. Mikhail noted that 2020 was, consequently, an unprecedented year for deep freezer sales. Most grocery shoppers won’t soon forget the perplexing moment last spring when shelves were suddenly bare.

Production 104

Production Sales Vaccination Vaccine 104

pharmaphorum

MAY 24, 2021

Modular content is an established practice among digital and content marketers in sectors such as FMCG and retail, who are challenged with increasing demand for more content and creating personalised content to meet the demands of their customers. Doing more in the digital space. Robb DeFilippis. A modular content ecosystem.

Marketing 102

Marketing Branding Sales Life Science 102

XTalks

MARCH 22, 2023

The cholesterol-lowering statin received its biggest boost in sales when a study found it was linked to a lower risk of heart attacks among those with heart disease. More potential patients equal more prescriptions which equals higher sales and bigger profits. Want to be a part of this shared future?

Life Science 97

Life Science Drugs FDA Approval Vaccination 97

Drug Discovery World

NOVEMBER 13, 2023

Thereafter, the following presentations will take place: Melody Shahsavarian, PhD, Digital Biologics Platform, Large Molecules Research, Sanofi, on: ‘Enhancing antibody discovery with generative AI’. Jeremy Fry, Dr, Director of Sales, ProImmune, on: ‘Mastering immunogenicity and biologics development’.

Protein 59

Protein Antibody Engineer Scientist 59